How does Rhopressa work?
Medically reviewed by Drugs.com. Last updated on Jan 12, 2021.
Rhopressa reduces intraocular pressure (IOP) by increasing outflow of aqueous humor (the fluid inside the eye) through the trabecular meshwork, the main fluid drain of the eye.
Rhopressa (netarsudil ophthalmic solution) 0.02%, from Aerie Pharmaceuticals, is a Rho Kinase Inhibitor. Rhopressa, a once daily eye drop for lowering IOP in patients with open-angle glaucoma or ocular hypertension, was FDA-approved in December 2017.
- Rhopressa Information for Consumers
- Rhopressa Information for Healthcare Professionals (includes dosage details)
- Side Effects of Rhopressa (detailed)